Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

Author(s):
Oosting, S.F.; Veldt, A.A.M. van der; Fehrmann, R.S.N.; GeurtsvanKessel, C.H.; Binnendijk, R.S. van; Dingemans, A.M.C.; Smit, E.F.; Hiltermann, T.J.N.; Hartog, G. den; Jalving, M.; Westphal, T.T.; Bhattacharya, A.; Wilt, F. de; Boerma, A.; Zijl, L. van; Rimmelzwaan, G.F.; Kvistborg, P.; Els, C.A.C.M. van; Rots, N.Y.; Baarle, D. van; Haanen, J.B.A.G.; Vries, E.G.E. de
Published
2022
Publication type
Other
Date issued
2022-06-27
Language
English
Publisher
ELSEVIER SCIENCE INC
hdl
1887/3565050
doi
10.1016/S1470-2045(22)00203-0